Diabetes mellitus and TB - finding strategies to reduce the double burden of disease

Affiliations

¹ Faculty of Medicine and Health, School of Pharmacy, University of Sydney, Sydney, NSW, Australia, Westmead Hospital, Sydney, NSW, Australia, Sydney Institute for Infectious Diseases, University of Sydney, Sydney, NSW, Australia, Department of Medicine, Division of Infectious Diseases, Karolinska Institutet, Stockholm, Sweden.
² Faculty of Medicine and Health, School of Pharmacy, University of Sydney, Sydney, NSW, Australia, Westmead Hospital, Sydney, NSW, Australia, Sydney Institute for Infectious Diseases, University of Sydney, Sydney, NSW, Australia.

Editorial

L Davies Forsman et al. Int J Tuberc Lung Dis. 2023.

. 2023 Feb 1;27(2):91-93.

doi: 10.5588/ijtld.22.0619.

¹ Faculty of Medicine and Health, School of Pharmacy, University of Sydney, Sydney, NSW, Australia, Westmead Hospital, Sydney, NSW, Australia, Sydney Institute for Infectious Diseases, University of Sydney, Sydney, NSW, Australia, Department of Medicine, Division of Infectious Diseases, Karolinska Institutet, Stockholm, Sweden.
² Faculty of Medicine and Health, School of Pharmacy, University of Sydney, Sydney, NSW, Australia, Westmead Hospital, Sydney, NSW, Australia, Sydney Institute for Infectious Diseases, University of Sydney, Sydney, NSW, Australia.

No abstract available

Comment on

Diabetes characteristics and long-term management needs in diabetic TB patients.
Koesoemadinata RC, McAllister SM, Soetedjo NNM, Santoso P, Dewi NF, Permana H, Ruslami R, Alisjahbana B, Critchley JA, Dockrell HM, Hill PC, van Crevel R. Koesoemadinata RC, et al. Int J Tuberc Lung Dis. 2023 Feb 1;27(2):113-120. doi: 10.5588/ijtld.22.0367. Int J Tuberc Lung Dis. 2023. PMID: 36853103 Clinical Trial.
Diabetes mellitus is not a predictor of poor TB treatment outcomes.
Baltas I, Sturdy A, Kavallieros K, McGregor A, Corrah T, John L, Cooke G, Whittington AM. Baltas I, et al. Int J Tuberc Lung Dis. 2023 Feb 1;27(2):140-145. doi: 10.5588/ijtld.22.0470. Int J Tuberc Lung Dis. 2023. PMID: 36853108
Therapeutic drug monitoring and TB treatment outcomes in patients with diabetes mellitus.
Alkabab Y, Warkentin J, Cummins J, Katz B, Denison BM, Bartok A, Khalil A, Young LR, Timme E, Peloquin CA, Ashkin D, Houpt ER, Heysell SK. Alkabab Y, et al. Int J Tuberc Lung Dis. 2023 Feb 1;27(2):135-139. doi: 10.5588/ijtld.22.0448. Int J Tuberc Lung Dis. 2023. PMID: 36853114 Free PMC article.